SCHEMBL2176451

SCHEMBL2176451

Clc1cc(Cn2cc(-c3cn4ccncc4n3)nn2)cc(Cl)c1Cl

nearest known ligand 0.42

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
KDR P35968 5/20 0.39
TEK Q02763 4/20 0.39
NR1I3 Q14994 6/20 0.37
ROCK2 O75116 2/20 0.36
PIM1 P11309 2/20 0.36
GSK3B P49841 2/20 0.36
AURKB Q96GD4 2/20 0.36
EPHB4 P54760 1/20 0.36
PDE3B Q13370 1/20 0.36
PDE3A Q14432 1/20 0.36
CLK1 P49759 1/20 0.35
DYRK1A Q13627 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12408998 0.91 KDR (0.40) KDRTEKNR1I3ROCK2PIM1
SCHEMBL2176814 0.82 NR1I3 (0.49) NR1I3
SCHEMBL2179089 0.80 SUV39H2 (0.39) NR1I3
SCHEMBL12408996 0.74 NR1I3 (0.48) NR1I3
SCHEMBL12408999 0.71 SUV39H2 (0.42) NR1I3
SCHEMBL2181543 0.65 ROCK2 (0.37) KDRNR1I3ROCK2PIM1GSK3B
SCHEMBL12408950 0.65 NPC1 (0.39) KDRTEKEPHB4
SCHEMBL1967731 0.65 NOTUM (0.38) ROCK2PIM1GSK3BAURKB
SCHEMBL1967033 0.65 CYP19A1 (0.47) NR1I3
SCHEMBL1970393 0.63 MAPT (0.41) KDRTEKNR1I3ROCK2PIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2350097-A1 HETEROAROMATIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE Merck Frosst Canada Ltd. (CA) 2011-08-03 EP disclosed
US-20110166152-A1 HETEROAROMATIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE MERCK FROSST CANADA LTD. (CA) 2011-07-07 US disclosed
US-20110166152-A1 HETEROAROMATIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE MERCK FROSST CANADA LTD. (CA) 2011-07-07 US disclosed
US-20110166152-A1 HETEROAROMATIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE MERCK FROSST CANADA LTD. (CA) 2011-07-07 US disclosed
WO-2010037225-A1 HETEROAROMATIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE MERCK FROSST CANADA LTD. (CA) 2010-04-08 WO disclosed
WO-2010037225-A1 HETEROAROMATIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE MERCK FROSST CANADA LTD. (CA) 2010-04-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110166152-A1 HETEROAROMATIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE SCD, SCD5, CPT1A KDR 2430/4885TEK 3973/4885NR1I3 310/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.